FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck | Schering-Plough | lawsuit | Vytorin

City to sue Merck, Schering-Plough

Tools

The city of New Haven, Connecticut will be suing Merck and Schering-Plough on the basis that Vyotrin doesn't work.

New Haven, which has spent $100,000 shy of a half million dollars on Vytorin and Zetia for employees, will seek reimbursement for the tax money it spent on the medications.   

While Merck did not comment, a Schering-Plough spokesperson said the company stood behind its product and would fight any challenge vigorously. 

- check out the Pharmalot blog entry 

Related Articles:
Analyst gloomy on Merck trends
Congress broadens Vytorin probe
Merck, Schering-Plough stocks take a dive
More bad Vytorin news for Merck, Schering
Vytorin scrips still falling, Hassan hires help


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Merck   Schering-Plough   lawsuit   Vytorin